Instil Bio Inc expected to post a loss of 41 cents a share - Earnings Preview

Instil Bio

03/03/2023 12:04

* Instil Bio Inc  TIL.OQ   TIL.O  is expected to show a rise
in
quarterly revenue when it reports  results on March 6
(estimated). 
    * The Dallas Texas-based  company is expected to report
revenue of
$500 thousand, according to the mean estimate from 2 analysts,
based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Instil Bio Inc is
for a
loss of 41 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Instil Bio
Inc is
$5​, above​ its last closing price of $0.76. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.45       -0.44      -0.43     Beat    1.4
 Jun. 30 2022  -0.38       -0.41      -0.46     Missed  -11.7
 Mar. 31 2022  -0.38       -0.38      -0.42     Missed  -9.6​
 Dec. 31 2021  -0.36       -0.36      -0.43     Missed  -18.6
 ​​Sep.        -0.32       -0.32      -0.33     Missed  -1.9
 30 2021                                                
 Jun. 30 2021  -0.21       -0.20      -0.27     Missed  -31.7​
 Mar. 31 2021  -0.52       -0.52      -0.66     Missed  -27.5
 This summary was machine generated March 3 at 12:04 GMT.  All
figures in US dollars  unless otherwise stated